BIO CEO & Investor Conference 2012

Now in its fourteenth year, the BIO CEO & Investor Conference is the largest independent investor conference focused on publicly-traded biotechnology companies.

Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.

The BIO CEO & Investor Conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.

BIO’s therapeutic workshops feature MDs, CSOs and industry analysts discussing the latest information on pipeline innovation for breakthrough therapeutic topics in biopharma.  Seasoned industry executives and analysts delve into timely and relevant business models, deal-making and investment trends on our business roundtables.